Keyword: United Kingdom

As Sanofi CEO Paul Hudson formulates a new strategy for the company, he visited the U.K. for a headquarters opening ceremony.

Aspen admitted to entering deals with potential rivals to keep a market monopoly, and then raised prices, CMA says.

Two drugmakers have admitted to sharing "commercially sensitive" information to keep prices high in the U.K.

Vertex hasn't been able to reach a deal for cystic fibrosis drug access in England, but in neighbor Scotland, the company has struck a five-year agreement.

U.K.-based CDMO PCI Pharma Services is expanding near Dublin as part of its “robust Brexit plan for continuity of pharmaceutical supply.”

Chinese biotech CMBG hopes to get a cell manufacturing facility built in nine months and more manufacturing news of note.

AstraZeneca attributes the swelling price tag on its new headquarters to design complexities, inflation and new technology.

Bristol Laboratories, whose partial suspension by European regulators in 2017 led to drug shortages, has had its license restored.

KD Pharma has snapped up a manufacturing site in Seal Sands, U.K., for an undisclosed price.

The new endorsement of Celgene's Revlimid from England's cost watchdog NICE may not help calm fears about BMS' $74 billion buyout.